NorthWest Biotherapeutics Inc (NWBO)

[antihama]

I agree basically w what you say which would be optimum but I don’t see BP giving top dollar just from drug approval. BP would have a hard time convincing their shareholders, who are not familiar w this paradigm shifting drug, of a justifiable partnership/buyout price. IMHO, NWBO would need to show BP and their shareholders/BOD that if they don’t pony up they’ll continue to go it alone till BP offers a buyout price or partnership in NWBOs ballpark. The United Kingdom is the training ground to show what DCVax-L is all about. The United Kingdom is that display window which will entice prospective buyers to step on in and check under the hood. That’s my view outside looking in which is akin to looking at the outside of a watch and trying to figure out how it works. Good luck w that and w what NWBO is thinking🙃. All IMHO.